+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested



Postgraduate Medical Journal 41(482): 718-739

Is still largely dependent on supportive care with blood transfusion and iron chelation. Since 1978, scientists and clinicians in this specialty have met regularly in an international effort to improve the management of thalassaemia, with the aim of increasing the expression of unaffected fetal genes to improve the deficiency in adult ?-globin synthesis. In this Seminar we discuss important advances in the understanding of the molecular and cellular basis of normal and abnormal expression of globin genes. We will summarise new approaches to the development of tailored pharmacological agents to alter regulation of globin genes, the first trial of gene therapy for thalassaemia, and future prospects of cell therapy.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 068885937

Download citation: RISBibTeXText

PMID: 21313715

DOI: 10.1136/pgmj.41.482.718

Related references

A genetic combination of silent beta-thalassaemia, high Hb A2 beta-thalassaemia, and single alpha globin gene deletion causing mild thalassaemia intermedia. Journal of Medical Genetics 21(2): 153-156, 1984

The clinical and haematological findings in children inheriting two types of thalassaemia: high-A2, type beta-thalassaemia, and high-F type or delta beta-thalassaemia. British Journal of Haematology 25(3): 375-384, 1973

A new beta zero-thalassaemia nonsense mutation (codon 112, T-->A) not associated with a dominant type of thalassaemia in the heterozygote. British Journal of Haematology 83(3): 523-524, 1993

The simultaneous presence of alpha- and beta-thalassaemia alleles: a pitfall of thalassaemia screening. Community Genetics 6(1): 14-21, 2003

Further data on genetics of microcythaemia or thalassaemia minor and Cooley's disease or thalassaemia major. Annals of Eugenics 16(4): 299-315, 1952

Beta-thalassaemia mutations in west Malaysia: a new thalassaemia clinical score system. Annals of the Academy of Medicine Singapore 23(1): 89-93, 1994

Haemoglobin synthesis in thalassaemia: two new molecular mechanisms for the production of the clinical picture of thalassaemia. Hamatologie und Bluttransfusion 10: 237-239, 1972

Further data on genetics of microcythaemia or thalassaemia minor and Cooleys disease or thalassaemia major. Annals of Human Genetics 16(1): 299-315, 1951

The risk of alpha-thalassaemia in offspring of beta-thalassaemia carriers in Hong Kong. Prenatal Diagnosis 17(8): 733-736, 1997

Prenatal diagnosis of thalassaemia major resulting from Lepore/ beta-thalassaemia genotype. Journal of Medical Genetics 18(6): 476-478, 1981

Molecular characterization of beta-thalassaemia in 174 Greek patients with thalassaemia major. British Journal of Haematology 74(3): 342-346, 1990

Thalassaemia of intermediate severity resulting from the interaction between alpha- and beta-thalassaemia. Journal of Medical Genetics 15(6): 448-451, 1978

Thalassaemia among Asians in Britain. Thalassaemia Society is working to improve awareness. BMJ 318(7187): 873, 1999

Co-inheritance of α-thalassaemia and β-thalassaemia in a prenatal screening population in mainland China. Journal of Medical Screening 21(4): 167-171, 2014

Erythrokinetics and iron status in heterozygous β thalassaemia, and the effect of interaction with α thalassaemia. British Journal of Haematology 66(1): 123-127, 1987